Sicor Inc.:
The Irvine specialty pharmaceutical company said net income for the second quarter totaled $6.9 million, or 7 cents a share. That compares with net income of $284,000 for the comparable quarter of 1999, which included charges of $1.8 million relating to the divestiture of a partial interest in Metabasis Therapeutics Inc. Revenue increased 31% to $71.8 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
